Memantine-induced decompensation in a patient with Lewy body dementia [4]

Annals of the Academy of Medicine Singapore

Volumn 36, Issue 8, 2007, Pages 707-

  Alisky, Joseph Martin ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA PLUS LEVODOPA; DONEPEZIL; GALANTAMINE; MEMANTINE; RIVASTIGMINE;

AGED; ALZHEIMER DISEASE; CASE REPORT; CLINICAL FEATURE; CONFUSION; CONSULTATION; DELUSION; DEMENTIA; DRUG SUBSTITUTION; DRUG THERAPY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; LETTER; LEWY BODY; NAUSEA; ORTHOSTATIC HYPOTENSION; PARKINSONISM; RIGIDITY; TABLET FORMULATION; TREATMENT OUTCOME; TREMOR; VISUAL HALLUCINATION;

EID: 34548489206     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Stewart JT. Defining diffuse Lewy body disease. Tetrad of symptoms distinguishes illness from other dementias. Postgrad Med 2003;113:71-5.
2. Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I, for the Memantine Study Group. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA 2004;291:317-24.
3. Sabbagh MN, Hake AM, Ahmed S, Farlow MR. The use of memantine in dementia with Lewy bodies. J Alzheimers Dis 2005;7:285-9.
4. Menendez-Gonzalez M, Calatayud MT, Blazquez-Menes B. Exacerbation of Lewy bodies dementia due to memantine. J Alzheimers Dis 2005;8:289-91.
5. Ridha BH, Josephs KA, Rossor MN. Delusions and hallucinations in dementia with Lewy bodies: worsening with memantine. Neurology 2005;65:481-2.
6. Kaufer DI, Catt KE, Lopez OL, DeKosky ST. Dementia with Lewy bodies: response of delirium-like features to donepezil. Neurology 1998;51:1512.